Lisa N. Gillespie, Ph D - Publications

Affiliations: 
Bionics Institute 
Area:
Auditory neuroscience
Website:
http://www.bionicsinstitute.org/our-staff/Pages/lisa-pettingill.aspx

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Cai HQ, Gillespie LN, Wright T, Brown WGA, Minter R, Nayagam BA, O'Leary SJ, Needham K. Time-dependent activity of primary auditory neurons in the presence of neurotrophins and antibiotics. Hearing Research. 350: 122-132. PMID 28463805 DOI: 10.1016/J.Heares.2017.04.014  0.653
2016 Wright T, Gillespie LN, O'Leary SJ, Needham K. Firing frequency and entrainment maintained in primary auditory neurons in the presence of combined BDNF and NT3. Scientific Reports. 6: 28584. PMID 27335179 DOI: 10.1038/Srep28584  0.426
2015 Gillespie LN, Zanin MP, Shepherd RK. Cell-based neurotrophin treatment supports long-term auditory neuron survival in the deaf guinea pig. Journal of Controlled Release : Official Journal of the Controlled Release Society. 198: 26-34. PMID 25481440 DOI: 10.1016/J.Jconrel.2014.11.026  0.687
2014 Gillespie LN, Richardson RT, Nayagam BA, Wise AK. Treating hearing disorders with cell and gene therapy. Journal of Neural Engineering. 11: 065001. PMID 25420002 DOI: 10.1088/1741-2560/11/6/065001  0.396
2014 Irving S, Gillespie L, Richardson R, Rowe D, Fallon JB, Wise AK. Electroacoustic stimulation: now and into the future. Biomed Research International. 2014: 350504. PMID 25276779 DOI: 10.1155/2014/350504  0.394
2014 Zanin MP, Hellström M, Shepherd RK, Harvey AR, Gillespie LN. Development of a cell-based treatment for long-term neurotrophin expression and spiral ganglion neuron survival. Neuroscience. 277: 690-9. PMID 25088914 DOI: 10.1016/J.Neuroscience.2014.07.044  0.677
2012 Wise AK, Gillespie LN. Drug delivery to the inner ear Journal of Neural Engineering. 9. PMID 23186937 DOI: 10.1088/1741-2560/9/6/065002  0.424
2005 Gillespie LN, Shepherd RK. Clinical application of neurotrophic factors: the potential for primary auditory neuron protection. The European Journal of Neuroscience. 22: 2123-33. PMID 16262651 DOI: 10.1111/J.1460-9568.2005.04430.X  0.643
2005 Gillespie LN, Marzella PL, Clark GM, Crook JM. Netrin-1 as a guidance molecule in the postnatal rat cochlea. Hearing Research. 199: 117-23. PMID 15574306 DOI: 10.1016/J.Heares.2004.07.004  0.568
2004 Gillespie LN, Clark GM, Marzella PL. Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport. 15: 1121-5. PMID 15129158 DOI: 10.1097/00001756-200405190-00008  0.681
2003 Gillespie LN. Regulation of axonal growth and guidance by the neurotrophin family of neurotrophic factors Clinical and Experimental Pharmacology and Physiology. 30: 724-733. PMID 14516410 DOI: 10.1046/J.1440-1681.2003.03909.X  0.464
2003 Gillespie LN, Clark GM, Bartlett PF, Marzella PL. BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival effects. Journal of Neuroscience Research. 71: 785-90. PMID 12605404 DOI: 10.1002/Jnr.10542  0.721
2002 Marzella PL, Gillespie LN. Role of trophic factors in the development, survival and repair of primary auditory neurons Clinical and Experimental Pharmacology and Physiology. 29: 363-371. PMID 12010177 DOI: 10.1046/J.1440-1681.2002.03684.X  0.62
2001 Gillespie LN, Clark GM, Bartlett PF, Marzella PL. LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport. 12: 275-9. PMID 11209934 DOI: 10.1097/00001756-200102120-00019  0.7
1999 Marzella PL, Gillespie LN, Clark GM, Bartlett PF, Kilpatrick TJ. The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro. Hearing Research. 138: 73-80. PMID 10575116 DOI: 10.1016/S0378-5955(99)00152-5  0.685
Show low-probability matches.